Spire Healthcare in Talks with Private Equity Firms over Potential £1.5 Billion Sale

Britain’s largest private hospital operator, Spire Healthcare Group, is reportedly in discussions with major private equity firms, including Bridgepoint and Triton Partners, regarding a potential acquisition that could value the company at around £1.5 billion. This development suggests that Spire may soon leave the London Stock Exchange.

Spire, which operates 38 hospitals and more than 50 clinics, medical centres, and consulting rooms, has attracted interest from these firms following pressure from investors, notably Harwood Capital Management. Investors believe that Spire is undervalued in the public market.

The healthcare group has been under scrutiny since it confirmed last September that it was considering takeover offers. The latest reports indicate that discussions remain at a preliminary stage, and there is no certainty that any formal offer will be made.

As of recently, Spire has faced challenges, including a profit warning due to decreased commissions from the NHS for private sector work. Its shares have fallen by over 20 percent since this announcement, highlighting the growing pressures on the healthcare operator amidst investor expectations.

Spire Healthcare collaborates with nearly 9,000 consultants and has provided care to more than 1.3 million patients in 2024 alone. The network not only includes private GPs but also offers occupational health services to more than 800 corporate clients, underscoring its prominence in the healthcare landscape.

Comments from Bridgepoint and Triton on the ongoing discussions have not been forthcoming. The implications of a successful acquisition would significantly influence the market positioning of Spire Healthcare and reshape its operational framework in the private healthcare sector.